Noticias de BSX_US
Noticias del mercado
Últimas noticias sobre BSX_US — 325 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Bragar Eagel & Squire, P.C. El socio litigante Brandon Walker anima a los inversores que sufrieron pérdidas en Boston Scientific (BSX) a ponerse en contacto con él...
Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says
Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating
Deutsche Bank Cuts Price Target on Boston Scientific to $75 From $90, Keeps Buy Rating
Truist Lowers Price Target on Boston Scientific to $85 From $90, Keeps Buy Rating
Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Alleged Concealment of Electrophysiology Demand Weaknesses: SueWallSt – Company…
Goldman Sachs Adjusts Boston Scientific Price Target to $84 From $87, Maintains Buy Rating
Bernstein Adjusts Price Target on Boston Scientific to $97 From $112, Maintains Outperform Rating
Raymond James Adjusts Price Target on Boston Scientific to $78 From $88, Maintains Outperform Rating
Leerink Partners Adjusts Price Target on Boston Scientific to $86 From $89, Maintains Outperform Rating
Evercore ISI Adjusts Price Target on Boston Scientific to $78 From $80, Maintains Outperform Rating
JPMorgan Adjusts Price Target on Boston Scientific to $80 From $100, Maintains Overweight Rating
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a
RBC Trims Price Target on Boston Scientific to $100 From $105, Keeps Outperform Rating
Rothschild & Co Redburn Adjusts PT on Boston Scientific to $106 From $110, Maintains Buy Rating
Página 8 de 17
